Real Time Touch

new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)

Real Time Touch

Filing Names

Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited_20100107
Takeda Pharmaceutical Company Limited_20100121
Takeda Pharmaceutical Company Limited_20100114

Takeda Pharmaceutical Company Limited patents

Recent patent applications related to Takeda Pharmaceutical Company Limited. Takeda Pharmaceutical Company Limited is listed as an Agent/Assignee. Note: Takeda Pharmaceutical Company Limited may have other listings under different names/spellings. We're not affiliated with Takeda Pharmaceutical Company Limited, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "T" | Takeda Pharmaceutical Company Limited-related inventors

Date Takeda Pharmaceutical Company Limited patents (updated weekly) - BOOKMARK this page
11/16/17Injection-needle cover
11/16/17Substituted 6-aza-isoindolin-1-one derivatives
11/09/17Methods and drug products for treating alzheimer's disease
11/02/17Heteroarylamide inhibitors of tbk1
10/05/17Heterocyclic compound
10/05/17Tetrahydropyridopyrazines modulators of gpr6
09/28/176-(5-hydroxy-1h-pyrazol-1-yl)nicotinamide inhibitors of phd
09/21/17Nitrogen-containing heterocyclic compound
09/14/17Nitrogen-containing heterocyclic compound
09/14/175-ht3 receptor antagonists
09/07/17Heterocyclic compound
08/17/17Heterocyclic compound
08/17/17Crystalline form of 1-(1-methyl-1h-pyrazol-4-yl)-n-((1r,5s,7s)-9-methyl-3-oxa-9-azabicyclo[3.3.1]nonan-7-yl)-1h-indole-3-carboxamide
08/17/17Method for proliferation of pancreatic progenitor cells
08/10/17Substituted piperidine compound and use thereof
08/03/17Nitrogen-containing heterocyclic compound
07/27/17Heterocyclic compound
07/27/17Production thienopyrimidine derivative
07/20/17Solid preparation
07/13/17Cationic lipid
07/13/17Heterocyclic compounds having cholesterol 24-hydroxylase activity
07/06/17Antibacterial water
06/29/17Cocrystal, production method thereof, and medicament containing cocrystal
06/22/17Heterocyclic compound
06/15/17Sustained-release composition and producing the same
06/15/17Piperidine derivatives for use in the treatment or prevention of psychiatric and neurological conditions
06/08/173-substituted 2-amino-indole derivatives
05/25/17Heterocyclic compounds and their use as retinoid-related orphan receptor (ror) gamma-t inhibitors
05/25/171-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases
05/18/17Method for treating depression and major depressive disorder
05/11/17Prophylactic or therapeutic agent for attention deficit/hyperactivity disorder
05/11/17Nitrogenated heterocyclic compound
05/04/17Method for producing heterocyclic compound
05/04/17Nitrogen-containing heterocyclic compound
04/27/17Radiolabeled compounds
04/27/17Pyridazinone compounds as phosphodiesterase inhibitors and methods of treating disorders
04/20/17Dihydroxy aromatic heterocyclic compound
04/20/17Amide compound
04/13/17Nitrogen-containing heterocyclic compound
04/13/17Nitrogen-containing heterocyclic compound
04/06/174-oxo-3,4-dihydro-1,2,3-benzotriazine as modulators of gpr139
04/06/17Heterocyclic compound
03/23/17Solid dispersion
03/23/17Process for producing heterocyclic compound
03/23/17Nitrogen-containing heterocyclic compound
03/16/17Substituted cyclopentanes, tetrahydrofuranes and pyrrolidines as orexin receptor antagonists
03/09/17Orally dispersible tablet
03/09/17Cyclic compounds
03/09/171,2-substituted cyclopentanes as orexin receptor antagonists
02/23/17Heterocyclic compound
02/16/17Heterocyclic compound
02/16/17Isoindoline-1-one derivatives as cholinergic muscarinic m1 receptor positive alloesteric modulator activity for the treatment of alzheimers disease
02/09/17Quinoxaline derivatives as gpr6 modulators
02/09/17Fused heterocyclic compound
02/02/17Nitrogen-containing heterocyclic compound
02/02/17Cyclopropanamine compound and use thereof
01/26/17Heterocyclic compound and use thereof
01/26/17Pharmaceutical preparation containing copolyvidone
01/19/17Dry coated tablet
01/19/17Pyridazine derivatives for use in the preventon or treatment of an ataxic disorder
01/19/17Pyridazine compound
01/19/17Heterocyclic compound
01/19/17Heteroarylamide inhibitors of tbk1
01/19/17Method for producing single crystal of polymer-metal complex
01/12/17Solid preparation
Patent Packs
01/12/17Method for producing sulfonyl chloride compound
01/12/17Pyrrolo[3,2-c]pyridine derivatives as tlr inhibitors
01/05/17Cyclopropanamine compound and use thereof
12/29/16Heterocyclic compound
12/29/16Sulfonyl piperidine derivatives and their use for treating prokineticin mediated diseases
12/15/16Uti fusion proteins
12/08/16Fused heterocyclic compound
12/01/16Heterocyclic compound
11/10/16Cyclic compounds
11/10/16Cyclic compounds
11/10/161-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases
11/03/164-(piperrazin-1-yl)-pyrrolidin-2-one compounds as monoacylglycerol lipase (magl) inhibitors
10/27/16Pyridinyl and fused pyridinyl triazolone derivatives
10/27/16Heterocyclic compound
Patent Packs
10/27/16Cyclopropanamine compound and use thereof
10/27/16Heterocyclic compound
10/27/16Cyclopropanamine compound and use thereof
09/15/16Heterocyclic compound
09/01/166-(5-hydroxy-1h-pyrazol-1-yl)nicotinamide inhibitors of phd
09/01/16Heterocyclic compound
09/01/165-ht3 receptor antagonists
08/25/16Production imidazole derivatives
08/18/16Heterocyclic compounds
08/11/16Heterocyclic compound
08/04/16Cyclopentylbenzamide derivatives and their use for the treatment of psychotic and cognitive disorders
07/21/16Amide derivatives as lysophosphatidic acid receptor antagonists
06/30/16Piperidine and azepine derivatives as prokineticin receptor modulators
06/30/165-ht3 receptor antagonists
06/23/16Fumagillol derivatives
06/23/16Heterocyclic compound
06/23/16Solid state forms of fused heteroaromatic pyrrolidinones
06/23/16Heterocyclic compound
06/23/16Heterocyclic compound
06/23/16Production poly(amino acid)
06/23/16Method for producing dopaminergic neurons
06/16/16Compounds for suppressing a peripheral nerve disorder induced by an anti-cancer agent
06/09/16Microneedle array and microneedle array manufacturing method
06/09/16Heterocyclic compound
06/09/16Heterocyclic compound
06/02/16Nitrogen-containing heterocyclic compound
06/02/16Nitrogen-containing heterocyclic compound
05/26/164-oxo-3,4-dihydro-1,2,3-benzotriazine modulators of gpr139
05/26/16Free base crystals
05/12/16Controlled release preparation
Social Network Patent Pack
05/05/161-sulfonyl piperidine derivatives as modulators of prokineticin receptors
04/28/16Controlled-release drug formulation
04/28/16Aromatic compound
03/31/16Orally disintegrable tablet
03/03/16Heterocyclic compound
02/25/16Heterocyclic compound
02/25/16Peptide compound
02/18/16Heterocyclic compound and use thereof
02/11/16Dihydroxy aromatic heterocyclic compound
02/11/16Heterocyclic compound
Patent Packs
01/28/16Heterocyclic compound
01/21/16A microneedle patch
01/21/16New modified nucleic acid
01/14/16Method for producing sulfonyl chloride compound
01/14/16Glucokinase activators
01/07/16Pharmaceutical compositions and methods for treating age-related macular degeneration with melatonin analogues
01/07/16Methods and drug products for treating alzheimer's disease
01/07/16Heterocyclic compound
01/07/16Production pyridazinone compounds
12/31/15Piperidin-1 -yl and azepin-1 -yl carboxylates as muscarinic m4 receptor agonists
12/31/151-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases
12/10/15Heterocyclic compound and use thereof
11/26/15Fused heteroaromatic pyrrolidinones
11/19/15Pyridazinones as daao enzyme inhibitors
11/19/15Substituted 2- amidoquinazol-4-ones as matrix metalloproteinase-13 inhibitors
11/05/15Heterocyclic compound
11/05/15Method for liquid-phase synthesis of nucleic acid
10/29/15Nitrogen-containing heterocyclic compound
10/29/15Nitrogen-containing heterocyclic compound
10/22/15Heterocyclic compound
10/15/15Cyclopropanamine compound and use thereof
10/15/15Conjugated anti-cd38 antibodies
10/01/15Substituted 6-aza-isoindolin-1-one derivatives
09/24/15Heterocyclic compound
09/24/15Cyclopropanamine compound and use thereof
09/24/15Production thienopyrimidine derivative
09/10/15Process for producing solid particles
08/27/15Fused heterocyclic compound and use thereof
08/20/15Novel compounds
08/13/156-(5-hydroxy-1h-pyrazol-1-yl)nicotinamide inhibitors of phd
Patent Packs
08/13/15Heterocyclic compound
08/13/15Fused heterocyclic compound
07/23/15Di-aliphatic substituted pegylated lipids
07/23/15Compounds for suppressing a peripheral nerve disorder induced by an anti-cancer agent
07/23/15Anti-cd38 antibodies
07/09/15Azaindole derivatives
07/09/15Heterocyclic compound and use thereof
07/02/155-ht3 receptor antagonists
06/25/15Tetrahydropyridopyrazines modulators of gpr6
06/18/15Liquid preparations of amines and organic acids stabilized by salts
06/11/15Solid preparation
06/11/15Pharmaceutical preparation for injection
06/11/15Heterocyclic compound
06/11/15Heterocyclic compound
06/04/15Aromatic ring compound
05/21/15Heterocyclic compound
05/21/15Solid preparation
05/14/15Dry-coated tablet
05/14/15Method for producing microcapsule powder
Social Network Patent Pack
05/14/15Method for assessing endometriosis
05/14/15Heterocyclic compound
05/07/15Heterocyclic compound and use therefor
05/07/15Administration of a raf inhibitor and a mek inhibitor in the treatment of melanoma
04/30/15Heterocyclic compound
04/23/15Enteric tablet
04/23/15Aromatic ring compound
04/23/15Sulfonyl piperidine derivatives and their use for treating prokineticin mediated diseases
04/09/15Pyridazinone compounds as phosphodiesterase inhibitors and methods of treating disorders
04/09/15Heterocyclic compound
04/02/15Heterocyclic compound
03/26/15Aromatic ring compound
03/19/15Sustained-release composition and producing the same
03/12/15Method for producing granules
03/12/15Heterocyclic compound and use thereof
02/26/15Novel compounds
02/19/15Heterocyclic compound and use thereof
02/19/15Compounds for suppressing a peripheral nerve disorder induced by an anti-cancer agent
02/19/15Rhodium catalyst and producing amine compound
02/12/15Heterocyclic compound
Social Network Patent Pack
02/12/15Tricyclic compound
02/12/15Aromatic ring compound
02/05/15Orally-disintegrating solid preparation
02/05/15Cinnoline derivatives
01/29/15Pyridazinone compounds and their use as daao inhibitors
01/29/15Poly (adp-ribose) polymerase (parp) inhibitors
01/22/15Benzimidazole compound crystal
01/15/15Benzimidazole derivatives as mch receptor antagonists
01/15/15Heterocyclic compound
01/15/15Aromatic ring compound
01/15/15Aromatic ring compound
01/01/15Indazole derivatives
12/04/14Peptide compound
11/20/14Proton pump inhibitors
10/16/14N-substituted oxazinopteridines and oxazinopteridinones
10/02/146-(5-hydroxy-1h-pyrazol-1-yl)nicotinamide inhibitors of phd
09/18/14Orally disintegrable tablets
09/11/14Pyrrolo [1,2-c] imidazole derivatives for use in the prophylaxis or treatment of cancer which is refractory to known cancer therapies
09/11/14Pyridinyl and fused pyridinyl triazolone derivatives
09/11/14Administration of dipeptidyl peptidase inhibitors
09/04/14Pyrimidinone compounds and their use
08/28/14Bicyclic compound
08/28/145- or 6-substituted 3-hydroxy-2(1h)-pyridinones as d-amino acid oxidase (daao) inhibitors in therapy of diseases such as schizophrenia, cognitive disorder and paid
08/21/14Heterocyclic compound
08/21/14Orally dispersible tablet
08/21/14Orally dispersible tablet
08/14/14Fused heterocyclic compounds as phosphodiesterases (pdes) inhibitors
08/14/14Heterocyclic compound
08/14/14Cyclopropaneamine compound
Social Network Patent Pack
08/07/14Thienopyrimidine compounds and use thereof
07/24/14Stable solid preparations
07/24/14Release control compositions
07/24/14Substituted 6-aza-isoindolin-1-one derivatives
06/19/14Diphosphine ligand and transition metal complex using the same
06/12/14Heterocyclic compound
06/05/14Preventives/remedies for stress urinary incontinence and screening the same
06/05/14Substituted pyrazolo[1,5-a] pyrimidines as calcium receptor modulating agents
06/05/14Prophylactic or therapeutic sjogren's syndrome
06/05/14Conjugated anti-cd38 antibodies
04/10/14Method and producing oxidized compound
04/10/14Production imidazole derivatives
03/27/14Heterocyclic compounds
03/27/14Heterocyclic compounds
03/20/14Heterocyclic compound and use thereof
03/20/14Fused cyclic compounds
03/06/14Heterocyclic compound
03/06/14Process for production of optically active amine derivatives
02/13/14Organ-specific gene, identifying the same and use thereof
02/13/14Fused ring compound and use thereof
01/30/14Pyrrole compounds
01/23/14Laminated tablet and manufacturing method therefor
01/23/14Sulfonamide derivative and use thereof
01/23/14Poly (adp-ribose) polymerase (parp) inhibitors
01/09/14Tricyclic compound and pharmaceutical use thereof
01/09/14Benzimidazole compound crystal
12/26/13Compounds for suppressing a peripheral nerve disorder induced by an anti-cancer agent
12/26/13Production optically active dihydrobenzofuran derivative
12/05/13Pyrazolo[4,3-b]pyridine-7-amine inhibitors of alk5

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009


This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. is not affiliated or associated with Takeda Pharmaceutical Company Limited in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Takeda Pharmaceutical Company Limited with additional patents listed. Browse our Agent directory for other possible listings. Page by